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Abstract: Palliative care has been increasingly shown to improve patient outcomes, in particular symptom 
management, quality of life and patient and family satisfaction. This has been shown within the care of 
people with cancer, neurological disease and heart failure but the methods by which palliative care is 
introduced earlier in the diagnosis is still complex. There are different models of increasing integration
care solely by the specialist, referral to other professionals or members of the team as necessary or an 
integrated model where palliative care interventions occur early in the disease progression. The evidence 
for the effectiveness of early involvement is being developed. The challenge for the future is increasing the 
awareness of professionals, patients and families that palliative care may be helpful and may improve the 
quality of life, and maybe the survival, of patients. The complex team interactions need to be acknowledged 
and all professionals involved to be focussed on improving the outcome for the patient and family.
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Introduction
Although in the past palliative care has often been seen 
to be synonymous with care at the end of life there is 
increasing discussion about a more integrated approach to 
care, with early integration of palliative care, with the aim 
of improving patient outcomes. This review will consider 
the evidence that is available for this integrated approach, 
and how different approaches to integration have been 
developed, according to local circumstances but also related 
to the disease group considered.
Within the definition of palliative care by the World 
Health Organisation there is no restriction in the timing of 
the intervention or restriction to any diagnosis or to end of 
life, but the care relates to any person with a life threatening 
illness. This definition states that palliative care is an 
approach that improves the quality of life of patients and their 
families facing problems associated with life-threatening illness, 
UISPVHIUIFQSFWFOUJPOBOESFMJFGPGTVGGFSJOHFBSMZJEFOUJòDBUJPO
and impeccable assessment and treatment of pain and other 
problems, physical, psycho-social and spiritual (1). However 
over the last 50 years as palliative care has developed there 
has been an emphasis on the care of people with cancer 
and towards the end of lifeas shown in Western Australia 
where 68% of the people dying of cancer received specialist 
palliative care whereas only 8% of those dying of non-
cancer conditions did so (2).
These views are now being challenged and there is 
an increasing pressure to have a palliative care approach 
from earlier after diagnosis and for an integrated approach 
with increased collaboration with other specialties to 
improve care, with an emphasis on the holistic care of 
patients and families. However there is often a confusion of 
terminology as to what is being considered to be palliative 
care and by whom it is provided (3). There is the duty of 
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all professionals to provide a holistic approach and also 
the need for a more specialised service for people with 
complex needs. The interaction between all these needs 
BOEUIFQSPWJEFSTDBOMFBEUPDPOGVTJPOBOEEJGòDVMUJFTGPS
all concernedpatients, families and professionals. The 
European Association for Palliative Care has suggested that 
there are different ways of palliative care provision as shown 
in Box 1.
Within oncology, and increasingly in the care of other 
disease groups, the concept of supportive care has been 
suggested. This aims to optimize the comfort, function and 
social support of the patient and family at all stages of the 
illness (4). This has been suggested to not only include all 
disease related therapy but includes patient directed therapy 
and family directed therapyincluding information, 
psychological support, rehabilitation, complementary 
therapies, pain management, social care, spiritual care, 
specialist palliative care and , as appropriate life
maintaining therapies, such as blood transfusion, ventilator 
support, hydration and feeding (5).
Thus how the care is provided may be complex with 
several different teams involved. The way services may be 
integrated within the existing specialist service is unclear 
and varies greatly. For instance within oncology different 
models have been suggested:
 Solo practicewhere the oncologist provides 
palliative care, but due to time and experience this 
may be limited;
 Congress practicewith the oncologist referring to 
various specialities to manage the issues, although 
this may be fragmented;
 Integrated carethe oncologist routinely refers 
patients for palliative care, with active collaboration (6).
Whereas in neurological care there has been close integration 
with palliative care being part of the multidisciplinary team and 
involved with all patients and their families from the time of 
diagnosis. These different models may depend on the disease 
progression as well as the circumstances within the service
differences in attitude, team working and availability of care. 
However the aim should be to improve the care for 
patients and their families and reduce symptom burden 
and maximize, or improve, quality of life. The approaches 
to integrated care will be considered for three areas in 
particular:
 Cancerwhere the disease progression may vary 
greatly and there may be the options of treatment 
that may potentially cure or slow the disease 
progression;
 Progressive neurological diseasewhere there 
is likely to be disease progression, over a varying 
period of time;
 Heart failurewhere there may be ambiguity of the 
prognosis as there is gradually diminishing functional 
status with periodic exacerbations of the illness (7).
These will be used an exemplars for the consideration 
of integrated care for other diseases, including those with a 
more sudden or more prolonged trajectory (7). 
Cancer
Over many years there has been increasing discussion of 
the integration of palliative care within oncology services. 
However there is increasingly a disease orientated approach 
to cancer care as there have been now developments in 
treatment, but this does not always lead to an improved 
quality of care (8). Health care costs in the USA have 
increased relative to outcomes and the holistic approach, 
considering the wider aspects of care including psycho-
Box 1 The European Association of Palliative Care descriptions of palliative care services
The palliative care approach is a way to integrate palliative care methods and procedures in settings not specialised in palliative care. 
This includes not only pharmacological and non-pharmacological methods for symptom control but also communication with patient and 
family as well as with other healthcare professionals, decision making and goal-setting in accordance with the principles of palliative care
General palliative care is provided by primary care professionals and specialists treating patients with life-threatening diseases who have 
good basic palliative care skills and knowledge. This includes professionals who are involved more frequently in palliative care, such as 
oncologists or geriatric specialists, but do not provide palliative care as the main focus of their work. They may have acquired special 
education and training in palliative care and may provide additional expertise
Specialist palliative care describes services whose main activity is the provision of palliative care for patients with complex problems not 
adequately covered by other treatment options. Specialist palliative care services require a team approach, combining a multi-professional 
team with an interdisciplinary mode of work. Team members must be highly qualified and should have their main focus of work in palliative 
care (3)
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social and spiritual, is often lost. However there have been 
several studies that have shown an improvement in patient 
outcomes when palliative care in included earlier in the 
disease progression and treatment.
In 2010 a study showed that early palliative care for 
patients with non-small cell lung cancer improved not only 
quality of life and mood, but led to a longer survival (9). 
Patients were randomised to standard care or early palliative 
care, when they were seen by a member of the palliative 
care team within 3 weeks and monthly as outpatients until 
death. One hundred and seven were fully assessed and the 
quality of life assessed by the Functional Assessment of 
Cancer Therapy-Lung Scale and found to be higher 98 
(scores 0136) in the patient group who received palliative 
care compared to 91.5 in the control group (P=0.03). The 
proportion of patients with depression, as assessed on the 
HADS score was lower in the palliative care group16% 
compared to 38% (P=0.01). The length of survival was 
11.6 months in the palliative care group compared to 
8.9 months (P=0.02) and this appeared to be primarily as 
the palliative care group received less aggressive care at the 
end of life33% compared to 54% (P=0.05). Thus the 
involvement of palliative care would seem to help patients 
decide on treatment options and reduce the risk of a more 
aggressive approach at the end of life.
A further study with newly diagnosed patients with lung 
and gastro-intestinal cancers involved 350 people, again with 
a monthly consultation with palliative care (10). There was 
again an improvement of quality of life after 24 weeks. The 
lung cancer patients showed an improvement in quality of 
life and depression at 12 and 24 weeks, whereas the control 
group deteriorated. The patients with gastrointestinal 
cancers also improved at 12 weeks. Patients were also more 
likely to discuss their wishes if they were dying with the 
oncologist30% compared to 14.5% (P=0.04). Caregivers 
were also assessed and showed improvement in total distress 
and depression at 12 weeks, but no change in quality of life 
or anxiety (11). These changes were not seen at 24 weeks, 
although the numbers were small. Thus these studies have 
shown that early palliative care intervention was helpful for 
both patient and caregiver.
Other studies have shown similar results. The ENABLE 
Trial used advanced practice nurses to lead educational 
sessions for patients combined with monthly group medical 
appointments. Quality of life improved and depression was 
lessened in the intervention group, although days in hospital, 
ICU or emergency department visits were unchanged (12). 
A further similar trial, ENABLE III, again offered a 
palliative care consultation, coaching sessions and monthly 
follow up for after enrolment or 3 months later (13). 
No changes were seen in symptoms or quality of life but 
the 1-year survival rates were 63% for the intervention and 
48% in the control group (P=0.038). It is unclear what may 
have led to these differences but the median participation 
was 240 to 493 days, and during this time relationships 
may have been developed with the palliative care team, 
XIJDINBZIBWFJOóVFODFEUSFBUNFOUEFDJTJPOTBOESFEVDFE
the more aggressive treatments, although these were 
not recorded. A study of the caregivers in ENABLE III 
showed that the early intervention favoured a reduction in 
depression and stress burden, but not quality of life or other 
burdens (14).
A further study in Canada involved 461 patients with 
cancer who were seen by a palliative care team within a 
month and then monthly whereas the control group were 
followed up within oncology (15). At 3 months there was 
some evidence of improvement in quality of life but by 
NPOUITUIFSFXFSFTJHOJòDBOUJNQSPWFNFOUTJORVBMJUZPG
life and symptoms. Patient satisfaction also improved.
In Italy, 207 patients were randomised to receive early 
palliative care consultation, followed by appointments 
very 2 to 3 weeks compared to standard oncological care 
with palliative care referral if requested (16). The early 
involvement of palliative care led to increased hospice care 
and admission to hospice and reduced chemotherapy in the 
last 30 days of life18.7% compared to 27.8% (P=0.036). 
There were non-significant reductions in hospitalisation, 
emergency room visits and hospital deaths. Thus again 
UIFSFTFFNUPCFCFOFòUTPGFBSMZJOWPMWFNFOUBOESFEVDFE
aggressive treatment at the end of life.
These papers do show the evidence that palliative care 
is helpful for patients with cancer. A systematic review of 
the effectiveness of specialist palliative care for terminally 
ill patients focussed on 22 trials (17). However only 13 
had quality of life as an outcome, and only in four was this 
a specified primary outcome. Only four studies showed a 
significant difference in quality of life, although this lack 
of evidence may reflect the lack of power in the samples, 
recruitment, attrition, contamination of control groups, 
randomisation problems in cluster studies and difficulties 
in assessing and detecting differences in quality of life. 
Fourteen studies assessed symptom management but 
again only one showed a significant benefit for individual 
symptoms but others did show improvement in symptom 
distress (17). Satisfaction with care was found to improve in 
only two of the 10 studies looking at this area. Overall there 
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was limited evidence, although this may have been due to 
the issues outline above (17).
A recent trial in Denmark has again showed no evidence 
for the effectiveness of palliative care, apart from in the 
management of nausea and vomiting (18). However no 
harmful effects of palliative care found and it was felt that 
UIFJOUFSWFOUJPONBZIBWFCFFOJOTVGòDJFOUBTUIFQBMMJBUJWF
care teams previous experience had been with advanced 
cancer and they may have perceived that the patients had 
few major issues and few contacts were made. Moreover 
there may have been increased care provided to the control 
group, either as the professionals compensated for the lack 
of palliative care by encouraging more medical contacts for 
the control participants or that the oncologists had become 
more experienced in palliative care and were providing 
better palliative care support (18).
Thus there does seem to be evidence that early palliative 
care is helpful for patients with advancing cancer and may 
help some symptoms, particularly depression, improve 
quality of life, reduce aggressive therapy at the end of 
life, caregivers, reduce hospitalizations, increase the use 
of advance directives and may reduce costs (8). However 
a review of the trials has shown that there are many 
methodological problems in these trialsof defining 
the usual care, when early applied, heterogeneity of 
populations, attrition, and a lack of an economic focus (8). 
This review suggested that new studies were necessary.
There is increased interest in providing palliative 
careeither as increased general palliative care within 
an oncological service or liaison and collaboration with 
specialist palliative care. As discussed above different models 
have been suggested:
 Solo practicewhere the oncologist provides 
palliative care, but due to time and experience this 
may be limited;
 Congress practicewith the oncologist referring to 
various specialities to manage the issues, although 
this may be fragmented;
 In tegra ted  carethe  onco log i s t  rout ine ly 
refers patients for palliative care, with active 
collaboration (6).
These concepts have been further developed and it has 
been suggested that the requirements of care are to focus on 
the patients particular needs, in particular:
 Acute needssuch as pain control;
 Chronic needs can then be consideredsuch as 
fatigue/anxiety/advance care planning;
 Psychosocial issues may be assessed and helped by a 
wider interdisciplinary approach;
 Existential/spiritual issues may then be considered;
 There is a need for ongoing support to allow the 
relationships to be developed, that may then allow 
the discussion of these deeper issues. A single visit is 
JOTVGòDJFOUUPBEESFTTBMMUIFJTTVFT	

Thus there are many models but often this is based on 
the assumption that a referral/involvement of specialist 
palliative care is necessary. However if patient care is to 
be improved there is a need for all services, including 
oncological services, to be able to provide general palliative 
care and be willing to refer for more specialist help if 
the issues are more complex. This referral to specialist 
services is often delayed, and the development of the term 
supportive care has aimed to help this (4,5), as palliative 
care a seen by many oncologists, and patients, as related to 
hospice and the end of life (20). Easier, and earlier, referral 
has been shown to help patient and families but a more 
holistic approach by all health and social care professionals 
would also help to improve care, at all stages of the disease 
progression.
The experience gained from the studies shows that 
there is a need to help oncologists see the holistic needs of 
patients and families and use their own teams to help and 
be willing to refer for palliative care support (20). The use 
of triggers to help in the referral has been suggested and 
regular screening of symptoms and other issues also enables 
all to be aware of issues that may need to be addressed (19). 
There is also the need for further education and training 
of oncologists, in training and in continuing education, 
and it has been suggested that oncologists could undertake 
accreditation in palliative medicine and be a resource within 
an oncology centre (19). There is also the need to ensure 
that resources are available to provide this extra support, 
although if less aggressive treatment is undertaken in the 
later stages of the disease and there is less hospitalization 
this support may be cost neutral (21).
The integration of palliative care within cancer services 
has been shown to be helpful and is continuing to be 
developed. This may be part of a wider medical, nursing 
and societal appreciation of the role of palliative care and 
will be discussed later.
Neurology
From the early days of St Christophers Hospice, London 
in 1967, the first of the new hospices providing palliative 
care in the UK, patients with progressive neurological 
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disease were admitted, as recorded in letters from Dame 
Cicely Saunders (22). The role of palliative care has been 
continued for many disease groups, but in particular motor 
neurone disease/amyotrophic lateral sclerosis (MND/ALS). 
The holistic care, involving careful symptom management 
and psychosocial/spiritual support of patients and families, 
has been shown to improve care and minimise the risk of a 
distressing death (23).
Over recent years there has been increasing awareness 
of the need to extend this palliative care approach to all 
neurological diseases and in 2016 the European Association 
for Palliative Care and the European Academy of 
Neurology produced a Consensus paper on palliative care 
in neurology (24). This recommended that palliative care 
should be integrated from early in the disease progression, 
depending on the diagnosisfor MND/ALS, which has a 
short prognosis of a mean of 23 years, this may be from 
diagnosis, and in Parkinsons disease (PD), with an average 
prognosis of 15 years this may be at a later stage (24). 
The use of triggers to help identify the deterioration and 
probable end of life was suggested (25). The triggers include 
swallowing problems, recurring infection, marked decline 
JOGVODUJPOBMTUBUVTòSTUFQJTPEFPGBTQJSBUJPOQOFVNPOJB
cognitive difficulties, weight loss and significant complex 
symptoms (25) and could allow neurological services 
to consider that death may be foreseen in the coming 
months and allow referral and involvement of palliative 
care services. Initial research has shown that the triggers 
do increase as death approaches and may be helpful in this 
prognostication, and subsequent referral (26).
There is also increasing evidence that palliative care is 
helpful in improving the patient outcomes and quality of 
life for people with progressive neurological disease. Studies 
in London for patients with multiple sclerosis (MS) showed 
that showed there was an improvement in symptoms in 
the group receiving palliative care, whereas there was 
deterioration in the control group (27). Moreover there 
was an improvement of caregiver burden (27) and this care 
was shown to be cost effective (28). A study in Turin in 
Italy considered a broader group of neurological diseases
MND/ALS, MS, PD and Parkinsons plus disordersand 
showed that the involvement of the wider multidisciplinary 
palliative care team led to improvement in symptomspain, 
breathlessness, sleep disturbance and bowel symptoms
and quality of life, but no significant changes in caregiver 
burden (29). However an Italian study on short term input 
in MS showed the involvement of specialist nurses, who 
had received extra training in palliative care and support, 
did lead to a reduced symptom burden but had no effect on 
quality of life or other outcomes (30).
There is also increasing evidence of palliative care 
becoming integrated into the multidisciplinary team (MDT) 
approach within neurological teams. This increasing 
emphasis on the MDT approach within neurology has been 
emphasized by the National Institute for Health and Care 
Excellence (NICE) for people with MND, where a MDT 
approach, including palliative care input, was recommended 
and found to be cost-effective (31). There are several 
studies showing that for people with MND/ALS that the 
involvement of a specialist MDTprofessionals with 
experience of the care of that particular disease and working 
closely together, and often including palliative careleads 
not only to a benefit in quality of life but an increased 
TVSWJWBM"TUVEZGSPN4IFGòFMETIPXFEBNFEJBOTVSWJWBM
of 19 months for those receiving MDT care, compared to 
11 months for the group who had received regular 
neurology follow up only (32). A study from Ireland showed 
again a survival advantage of the specialised MDT approach 
with a median survival of 1.22 years for the MDT group 
compared to 0.98 years for the control group (33). Both of 
these studies are open to bias as they have used retrospective 
cohorts as a control (32) or a control group from a different 
area (33), but there does seem to be increasing evidence that 
the MDT team, which encompasses a holistic approach and 
provides general palliative care, is helpful in both quality 
and length of life.
Within stroke services the role of palliative care is more 
complex, as this is a sudden event and patients and families 
face an unexpected serious prognosis. An Australian study 
found that 50% of the patients who died in the stroke unit 
had been completely independent and well prior to the 
stroke (34). Guidelines stress the need for palliative care, 
particularly for patients who have a catastrophic stroke or 
who have pre-existing morbidity (35) and recommend that 
palliative care principles should be seen as a key component 
in stoke care. There were recommendations for the 
recognition the symptom issues that may occur, ensuring 
good communication with patients and families, particularly 
in prognostication and negotiating management plans, and 
stroke services would be expected to provide the majority 
of palliative and end of life care with support from specialist 
services if necessary (35,36). Creutzfeldt has suggested the 
use of a Palliative care needs checklistconsidering: 
 Does this patient have pain or distressing symptoms?
 Do the patient and/or family need social support or 
help with coping? 
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 Do we need to readdress goals of care or adjust 
treatment according to patient-centred goals?
 What needs to be done today? (36)
Thus the recognition of palliative care needs is essential 
and most patients can be assessed and managed by the 
stroke team, with consultation with specialist services when 
the issues are more complexoften with more complex 
decision making at end of life (34).
Within dementia care there has also been an increasing 
emphasis on ensuring patients receive appropriate palliative 
care. The EAPC White Paper reinforced this opinion, and 
a Delphi study of international experts rated the importance 
of palliative care at 8.3/10 and palliative care was felt to be 
important for all people with dementia and should not be 
restricted to those with severe dementia (37). There is the 
need for all professionals involved in the care to use the 
principles of palliative care throughout the patients disease 
progression. As the patient approaches end of life these 
issues may be more pronounced, ensuring that the patient 
is comfortable and avoiding over burdensome or futile 
treatments (37,38). As many patients with dementia will be 
within nursing or residential homes palliative care should 
be a major role within these institutions and palliative care 
skills developed for the professionals (38).
Thus there is some evidence that patient outcomes do 
seem to improve with early palliative care involvement, 
with improvements in symptoms, quality of life and maybe 
survival, although this evidence is from small studies and 
predominantly, but not exclusively, for MND/ALS. The 
evidence is not as well developed as in cancer but there are 
studies showing that there is a clear improvement in quality 
of life and symptom burden (27,29). The Consensus paper 
stressed the need for further education, of neurologists in 
palliative care and palliative care specialists in neurology, to 
enable the approach to develop further (24).
Heart failure
The role of palliative care for heart failure has increased 
over the last 10 years and in the Heart Failure Association/
European Society of Cardiology Guidelines on the 
treatment of acute and chronic heart failure palliative care 
is suggested early in the disease progression, increasing as 
the disease progresses (39). The Guidelines also suggest 
ongoing discussion regarding the management plan and 
emotional/social/spiritual support (39).
There are studies showing that palliative care can 
help in the management of symptoms and the well-being 
of patients. The PREFER study in Sweden considered 
the effectiveness of a home based palliative care service 
compared to usual primary care (40). The results showed 
an improvement in quality of life, nausea, total symptom 
CVSEFOTFMGFGòDBDZBOESFEVDFEIPTQJUBMJ[BUJPOT	
5IF
care offered differed to many palliative care teams in as 
much as the PREFER team would also manage the heart 
failure and any other co-morbidities, in collaboration with 
the primary care team. This was important in improving 
symptoms, as active heart failure management was used in 
conjunction with palliative procedures and medication.
A study of an out-patient palliative care consultation, 
usually before discharge from hospital, in California showed 
improvement, at 3 months, for symptom burden, depression 
and quality of life (41). These patients were all symptomatic 
with the heart failure and this was a single consultation, 
when a management plan was drawn up in collaboration 
with the patient and family. A study in Hong Kong assessed 
patients at home, followed by ongoing support in person 
or by telephone (42). Although there was improvement in 
assessed quality of life, higher patient satisfaction and lower 
caregiver burden at 12 weeks, there was no difference in 
symptom distress or functional status (42).
In one study an embedded approach was assessed, where 
a clinical nurse specialist from palliative care met weekly 
with the cardiac team to identify eligible in-patients (43). 
After discharge from hospital a community based palliative 
care nurse practitioner provided 24/7 symptom management 
support with the involvement of other members of the 
multidisciplinary team, as necessary. The interventions led 
to an increase in advance care planning and high levels of 
patient and family satisfaction but no change in hospital 
visits or readmissions (43).
As there is great variability in the progression of heart 
failure the use of needs assessment has been suggested 
to help identify patients who may have palliative care 
needs. . The Needs Assessment Tool:Progressive Disease-
Heart failure (NAT:PD-HF) was found to be easy to 
administer and was a potential way of identifying physical 
and psychosocial issues (44). The Integrated Palliative 
care Outcome Scale (IPOS) has been shown to be feasible 
for use in ascertaining the issues important to the patient 
with heart failure (45) and was found to be acceptable and 
not burdensome to patients, allowing their views to be 
ascertained easily in clinical settings (45). These measures 
may be an easier way for the palliative care issues to be 
identified for this complex group of patients, allowing 
resources to be targeted appropriately and effectively.
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Thus palliative care involvement in the care of heart 
failure patients was often by referral or involvement of 
specialist palliative care teams and the use of scales could 
help facilitate referral. However there are still major gaps 
in access to palliative care and a UK study showed that only 
58% of palliative care teams reported collaboration with 
cardiology teams and this was often as ad hoc joint working 
(71%) rather than pre-planned MDT meetings (37%), 
working groups (21%) or mutual education (36%) (46).
There does seem to be evidence that palliative care 
involvement in the care of people with heart failure may 
improve symptoms, help with psychosocial issues, aid 
advance care planning and increases quality of life for 
patients and families. The approach has been often by 
referral to other services but an embedded approach, 
with regular interactions between the palliative care and 
cardiology teams seems to be very helpful.
Discussion
There is increasing, but limited, evidence that the involvement 
of palliative care earlier in the disease progression may lead 
to improvement in quality of life, symptom management, less 
aggressive treatment at the end of life and maybe survival as 
has been shown in the studies described above. However the 
evidence is varied and there are many issues within studies, 
relating to recruitment, retention, attrition of participants and 
the design of studies.
Two large systematic reviews have also considered the 
effective of palliative care on quality of life (47) and patient 
and carer outcomes (48) and showed small effects on 
quality of life. A meta-analysis of 43 trials, involving 12,371 
patients, found a statistically and clinically significant 
improvement of quality of life, although this effect was 
MFTTFOFEXIFOPOMZUIFòWFUSJBMTXJUIBMPXSJTLPGCJBTXFSF
analysed (48). There have been other studies suggesting 
that homebased palliative care may reduce admissions to 
hospital and increase hospital involvement for people with 
frailty, advanced heart failure, COPD on home oxygen, 
metastatic cancer and severe dementia (49), with reduced 
healthcare costs. This was also shown in Australia where a 
home based service reduced hospital admissions and bed 
days and costs of acute care in the last year of life (50). 
Barriers were found to the early involvement of palliative 
care in hospital, including the staging of the disease, staff, 
patient and organizational barriers (51). The use of triggers 
to allow patients with palliative care need to be identified 
and then assessed was suggested (51).
As well as there being limited evidence for the 
involvement of palliative care, there is also a lack of clarity 
in how this could be provided. This is further complicated 
by the lack of clarity as to what is provided by palliative 
carefrom general care to specialist team involvement, as 
shown in Box 1.
The models suggested by Bruera and Hui for cancer 
care could apply equally to other disease groupsfrom an 
independent practitioner approach to a congress approach 
to an integrated team approach (6). They have also 
suggested that there could be a provider based approach 
with increasing expertise from primary care to specialist 
palliative care (Figure 1) (19). However with this model 
there is a need for all health professionals to be aware of 
potential palliative care needs and to be able to address 
these, to a variable extent. A patient with minor symptoms 
may be cared for by a primary care team without any 
problems but more complex patients may require a more 
specialist approach. This may be by the use of regular 
assessment of patients needs, using a needs based tool, with 
triggering of more specialist help if issues are found. There 
are still issues about the timing of this onward referral, the 
availability of an infrastructure to respond to the referral, 
BOEUIFJTTVFTPGUFSNJOPMPHZ	
"MUIPVHIUIFEFòOJUJPOT
of the various aspects of palliative care seem to be clear 
the reality may be more complexas professionals may 
be reluctant to talk of palliative care or about possible 
QSPHSFTTJPOBOEEFBUIQBUJFOUTNBZòOEQBMMJBUJWFDBSFMFTT
acceptable and refuse to be involved and families may resist 
involvement as this is seen as accepting the progression and 
inevitability of death and losing hope (20).






Figure 1 Palliative care subtypesprimary, general and specialist
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professional seeing the patientoncologist, cardiologist, 
neurologist or other specialistthere may be delays as 
they find coping with these issues more difficult (19). If 
all patients have palliative care involvement, within an 
integrated model, this is lessened (6,19). However there 
may still be a variation in the skills of professionals and 
what seems to be clear lines of skill and involvement may 
vary from practitioner to practitioner (Figure 2). Some 
professionals, who feel that they lack the experience or skills 
UPNBOBHFUIFJTTVFTPGQBMMJBUJWFDBSFPSòOEJUEJGòDVMUUP
face these issues and discuss with patients may have a very 
low threshold to refer and involve other teams, early, and 
maybe inappropriately (Figure 2A). The more experienced 
professionals or teams may require less support from 
specialist teams (Figure 2B). Thus the referral may depend 
as much on the practitioner as the patient and family and 
their issues.
There is the need for further development in awareness, 
recognition of needs and ability to manage the issues that 
may arise. Another model has been to develop, through 
education, the primary professional team, as has been 
suggested for stroke care (34,36). This may improve 
the outcomes, but does depend on the attitudes and 
awareness of these teams (6). There is also the need for 
close collaboration with specialist palliative care services 
for advice and support with more complex issues. There 
are also issues of how the resources and time would be 
found for this education and the ensuing assessment at all 
consultations. 
Increased collaboration and interaction between all 
involvedprimary care, specialist teams and specialist 
palliative careis another model for the future. This was 
shown in both the support of cancer and heart failure with 
either a palliative care assessment (10,15,16,41) or a member 
of the MDT providing palliative care (32,33,43). This 
will require increased education and the opportunities for 
teams to work together. This may be complex as although 
everyone assumes teams work in similar ways, there are often 
major differences in ethos, leadership styles, team dynamics, 
multidisciplinary working practices, and attitudes (53). These 
may need to be recognized and addressed for the care of 
patients and families to be maximized. There will also need 
to be clarity as to how the interaction will be undertaken. 
The use of regular assessment and triggering of palliative 
care within a clear pathway is one way forward. Education 
is needed for all involved, not only in the practical issues of 
patient carephysical, psychosocial and spiritual issues
but also the wider discussion and consideration of ethos, 
attitudes, coping with dying and death, coping with the more 
profound issues of both patient and family and how teams 
work individually and interact with others (53).
It has been suggested that palliative care may be needed 
episodically throughout the disease progressionas shown 
in Figure 3 (54). This was developed for neurology, but could 
be applied to all progressive diseases, as there has been the 
change from palliative care only being considered at end of 
life (as in Figure 3A), to a gradual change over time from 
the care of neurology or other specialities to palliative care 
(Figure 3B) to episodic care, according to need (Figure 3C). 










Figure 2 Variations in palliative care involvement. (A) Primary care team with limited skills and increased referral to specialist palliative 
care; (B) primary care team and generic team have very good skills and reduced referral to specialist palliative care.
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diagnosis, when they face this little known disease and its 
implications, when gastrostomy may be considered, when 
non-invasive ventilation is assessed for cognitive change and 
towards the end of life, and this may be over a period of 2 to 
3 years. For a more chronic disease the needs may arise over 
a longer period of time, even many years, but palliative care 
may be helpful for particular issues as the disease progresses. 
There will be the need for the specialist team to continue to 
be involved for many disease groups, as for instance in heart 
failure the adjustment of medication for the disease process 
itself can be helpful in managing symptoms, in association 
with palliative care interventions. This pattern of care may 
be applied for all diagnoses, as many diseases become more 
chronic, with variable exacerbations, and are faced by patients 
who have several comorbidities and the issues of ageing and 
frailty.
There is a challenge as to how the integration of palliative 
care can be improved, with the aim of improving patient 
outcomes. The evidence presented above suggests that the 
closer involvement and awareness of palliative care within any 
specialised service does tend to improve patient outcome
quality of life, symptom burden and possibly survival. There is 
uncertainty as to the best way to facilitate this improvement, 
but closer collaboration, imbedding of palliative care within 
teams, education of all involved in care to increase awareness of 
the palliative care needs of patients and families, clear pathways 
for referral and assessment of palliative care needs, availability 
PGUIFSFTPVSDFTUPBMMPXBTTFTTNFOUBOETVQQPSUBOEóFYJCJMJUZ
in the provision of palliative care. 
Moreover there is the need to ensure that all involved
patients, families and professionalsare aware of the 
QPUFOUJBMCFOFòUTPGQBMMJBUJWFDBSFBTUIFSFBSFTUJMMNBOZ
who see palliative care involvement only at the end of life. 
There is often resistance to assessment and involvement 
of palliative care as this adds to the fear of the future. The 
myths and fears of palliative care need to be faced and 
addressed by patients and families, professionals and wider 
society for palliative care to become more acceptable (55). 
There is the need for education at all levels and throughout 
society, so that patients and families are able to receive the 
care they need so that their outcomes may improve, and 
their quality of life is maximized, and death may be peaceful, 











The traditional model of late involvement of specialist palliative services
Neurology and medical specialties
Neurology and medical specialties











The model of early and increasing involvement of specialist palliative services
The model of dynamic involvement of palliative services based on trigger points
Figure 3 Palliative care involvement with medical specialties. Taken with permission from Bede et al.
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